ONE LIFE
Innovation in food and feed: keeping safety assessments fit for purpose
Current societal demands call for more sustainable food and feed production systems and healthier food and feed products and diets. This demand is at the heart of European policies such as the Green Deal and Food2030 . Through these policies, Europe is pursuing its ambition for the development of innovative and high-quality food and feed products that are safe and produced in a more sustainable manner. Hence, a wide range of innovative food and feed products is expected to reach the EU market in the future and novel (production, processing and application) technologies be applied (e.g. new or alternative protein sources, new whole foods and feeds such as insects or algae, in vitro meat or food and feed products obtained through synthetic biology, 3D food printing and nanotechnology). Some of these developments may pose risk assessment challenges, requiring new or updated safety assessment approaches. We will therefore explore risk assessment development needs for innovative food and feed products, and discuss how risk assessment approaches and post-market surveillance may need to be advanced to safeguard the safety of future food and feed. This should ensure preparedness and address societal demands for better protection of human and animal health as part of the One Health approach.
Session Coordinator
Session Contributors
CONFIRMED PROGRAMME AFFILIATES
- Helle Katrine Knutsen, Norwegian Institute of Public Health (NPIH)
- Emmanuelle Pic, French Agency for Food, Environmental and Occupational Health & Safety (ANSES)
- Remko Boom, Wageningen University - Safety of innovative foods and the role of processing
- Matias Zurbrigen, University of Dusseldorf - Synthetic biology – safety considerations
- Kimberly Ong, Vireo Advisors - Cell-cultured meat: Safety considerations and research priorities
- Daniela Battaglia, Food and Agriculture Organization of the United Nations (FAO) - Safety of alternative and innovative feed sources and technologies in the context of sustainable development
- Gabriele Reichmann, Paul-Ehrlich-Institut - Safety of proteins - lessons from non-clinical assessment and in silico prediction of immunogenicity of therapeutic proteins
- Samuel Godefroy, University of Laval - General recommendations on safety assessment of innovative products and technology
- Katrina Sichel, Wit and Word Communications
- Daniela Battaglia, Food and Agriculture Organization of the United Nations (FAO)
- Remko Boom, Wageningen University
- Kimberly Ong, Vireo Advisors
- Gabriele Reichmann, Paul-Ehrlich-Institut
- Matias Zurbrigen, University of Dusseldorf
- Michele Ardizzone, European Food Safety Authority (EFSA)
- Antonio Fernandez Dumont, European Food Safety Authority (EFSA)
- Winny Messens, European Food Safety Authority (EFSA)
- Reinhilde Schoonjans, European Food Safety Authority (EFSA)